The new WHO recommendations aim to help preserve the effectiveness of antibiotics that are important for human medicine by reducing their unnecessary use in animals. “A lack of effective antibiotics is as serious as a security threat as a sudden and deadly disease outbreak”, says Dr Tedros Adhanom Ghebreyesus, Director-General of WHO.
Call for comments on a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform
DEADLINE: 22 December 2017 The World Health Organization is partnering with Médecins Sans Frontières (MSF) and the Foundation for Innovative New Diagnostics (FIND) to develop a target product profile (TPP) for a semi-open multiplex multi-analyte diagnostic platform. This platform will help better diagnose the millions of people presenting with severe febrile illness without a known source in low- and middle-income countries.
2 November 2017 -- The rise of antibiotic resistance is leading to untreatable infections which can affect anyone, of any age, in any country. Without urgent action, we are heading for a future in which infections and minor injuries could once again kill. Download animated GIFs and JPGs for social media posts on this topic.
19 September 2017 - A new WHO report finds that very few antibiotics currently in development address the serious and growing threat of antimicrobial resistance. The report shows a lack of potential treatment options for drug-resistant tuberculosis and 12 other classes of priority pathogens identified by WHO. Tuberculosis is responsible for about 250 000 deaths a year and some of the other pathogens, such as GRAM-negatives, can kill patients in just a few days due to the lack of treatment options.
Informal Member State Consultation on the Global Framework for Development and Stewardship to Combat Antimicrobial Resistance
9-10 November 2017
Location: Geneva, Switzerland
Member State Meeting participants can sign up until 20 October 2017
7 July 2017 – Data from 77 countries show that antibiotic resistance is making gonorrhoea – a common sexually-transmitted infection – more difficult, and sometimes impossible, to treat. Some countries – particularly high-income ones, where surveillance is best – are finding cases of the infection that are untreatable by all known antibiotics. These cases may just be the tip of the iceberg, as gonorrhoea is more common in lower-income countries.
WHO, FAO and OIE have launched the Global database for Antimicrobial Resistance Country Self-Assessment. For the first time, status of countries regarding the actions taken to implement the global action plan to address antimicrobial resistance is now available in an open access global tripartite database. All responses to the country self-assessment questionnaire sent out in 2016 can be found in the database with answers visualized through maps and in table form.
Antimicrobial resistance (AMR) is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others.
About antimicrobial resistance (AMR)
- Fact sheet on antimicrobial resistance
- Fact sheet on antibiotic resistance
- Questions and answers on AMR
- 10 Facts on antimicrobial resistance
- Q&A: Why is vaccination important for addressing antibiotic resistance?
- Q&A: What is multidrug-resistant tuberculosis?
Global action plan (GAP) on antimicrobial resistance
Implementation of the global action plan
- Awareness and education
- Surveillance of antimicrobial resistance
- Infection prevention and control
- Optimal use of antimicrobial medicines in human and animal health
- R&D and investment
National action plans
News and media
Why talking about sex is good for your health
UN announces interagency group to coordinate global fight against antimicrobial resistance
WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens
WHO publishes list of bacteria for which new antibiotics are urgently needed
WHO recommends 29 ways to stop surgical infections and avoid superbugs
Resources and publications
Handle Antibiotics With Care: Tripartite Brochure
- WHO list of critically important antimicrobials for human medicine (CIA list) - 2017
- National action plan manual
- Antibiotic resistance: Multi-country public awareness survey
- Worldwide country situation analysis: response to antimicrobial resistance
AMR Behaviour Change Consultation Report 6 and 7 Nov 2017
LSHTM Antibiotic Prescribing and Resistance: Views from LMIC Prescribing and Dispensing Professionals 2017
Join our online Community of Practice
Are you developing/implementing a national action plan to address antimicrobial resistance? Would you welcome an opportunity for informal peer-to-peer discussions and/or access to prompt technical advice for operational challenges? The Community of practice holds a library of resources, from many different stakeholders, on a range of topics relevant to national action plans
Time-limited discussion series Sept 2017-March 2018
The AMR NAP online Community of Practice is holding a series of time-limited discussions on the following topics from September 2017 – March 2018 and would appreciate your input to the discussions. You can also view past discussions. Register here:
Next scheduled discussion 5-9 March 2018:
Resistance in disease and areas
Call for consultants
AMR in the WHO Regions
- Informal Member State Consultation on the Global Framework for Development and Stewardship to Combat Antimicrobial Resistance
- Meeting on monitoring of antimicrobial resistance: outcome and goal indicators - 8-9 June 2017
- Meeting of the WHO AMR Surveillance and Quality Assessment Collaborating Centres Network - 13-14 December 2016
- 2nd Meeting of the Global Antimicrobial Resistance Surveillance System (GLASS) Collaborative Platform - 15-16 December 2016